ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-upNicoletta Colombo, Alain G. Zeimet, Denis Querleu et al.|Annals of Oncology|2015Cited by 1.4k
Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors <b> <i>in Vivo</i> </b>Nicole Concin, Ute M. Moll, K Becker et al.|Cancer Research|2004Cited by 137
Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancerGerda Hofstetter, Robert Zeillinger, Astrid Berger et al.|Oncogene|2010Cited by 81
Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.Helmut W. Ott, Karl Illmensee, Bettina Sarg et al.|PubMed|2003Cited by 79